Company Profile
Biocon manufactures and sells biotechnology products and research services globally. Its business is organized into Generics, Biosimilars, and Research segments. The company offers generic formulations and API products, including cardiovascular, anti-diabetics, obesity, multiple sclerosis, anti-fungal, anti-cancer, immunosuppressants, and specialty molecules
Biosimilars products consisting of pegfilgrastim, trastuzumab, bevacizumab, adalimumab, etanercept, ustekinumab, glargine, aspart, insulins, and aflibercept integrated discovery, development, and manufacturing services to pharmaceutical, biotechnology, animal healthcare, consumer goods, and agrochemical companies.
Additionally, it offers enzyme, biopharmaceutical, and medicinal goods contract research and manufacturing services, and R&D in the fields of pharmaceuticals, drug discovery, biotechnology pharmaceuticals, and medicinal sciences, etc.. Its portfolio also includes clinical research, and business support and development, and marketing services. Incorporated in 1978, Biocon is headquartered in Bengaluru, India.